Comprehensive Review: Pediatric Gonadal Germ Cell Tumor Therapies

This report provides a comprehensive overview of current and emerging therapies for pediatric gonadal germ cell tumors, which are rare tumors primarily affecting the ovaries and testes. The report begins with an introduction that outlines the prevalence, classification (benign and malignant), and common symptoms of these tumors. It then delves into basic research results, exploring the role of chemotherapy (including drug combinations and cisplatin-containing regimens), immunotherapy (including non-specific, oncolytic virus, T-cell, and monoclonal antibody therapies), and radiotherapy in the treatment of these tumors. The report further examines results from preclinical and clinical studies, focusing on pathology, clinical characteristics, and treatment approaches, including surgical interventions like ovariectomy or ovariosalpingectomy. The report highlights the importance of early diagnosis, staging procedures, and the selection of appropriate treatment modalities based on tumor type and stage. The report emphasizes the critical role of surgical resection, chemotherapy, and the evolving landscape of immunotherapies and radiotherapy in improving outcomes for children with gonadal germ cell tumors. The report also highlights the importance of understanding tumor markers such as alpha-fetoprotein and beta subunit of the patient chorionic gonadotropin in diagnosis and monitoring treatment response. The report concludes by summarizing the key findings and implications for the future of pediatric gonadal germ cell tumor management.

Running head: CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM
CELL
CURRENT AND EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM
CELL TUMORS (testicular and ovarian)
[Author Name(s), First M. Last, Omit Titles and Degrees]
[Institutional Affiliation(s)]

2
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Table of contents
Topic Page
Abbreviations………………………………………………………………………… 1
Summary……………………………………………………………………………..2
Introduction……………………………………………………………………………3
Basic research results…………………………………………………………………5
Results from preclinical and clinical studies…………………………………………..7
Discussions…………………………………………………………………………….9
Conclusion……………………………………………………………………………..12
References……………………………………………………………………………….13

3
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Abbreviations
GCTs: gonadal cell tumor; ALK: Anaplastic lymphomas kinases; DCR: Diseases controls
rate; EGFR: Epidermal growth factor receptor; NSCLC: Non-small cells lung cancers; ORR:
Overall responses rates; PD: Progressive diseases; PR: Partial responses; SD: Stable diseases

4
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Summary
Pediatric germ cell tumors are very rare tumors. Eighty percent of these tumors are benign
while the rest are malignant. The gonadal parts usually the ovary and the testis usually they
account for over forty percent of these cases (Amatruda, 2015).
Ovarian gonadal cell tumors they represent thirty percent of the gonadal germ cell tumors and
also seventy percent of neoplastic masses of the ovary. This type of gonadal germ cell tumors
is the most witnessed teenagers and children (Brook, 2012). Benign and the other immature
form constitute almost eighty percent of gonadal cell germ tumors. Malignant forms of the
gonadal cell germ tumors represent 20 percent of the tumors which occur during the
adolescence. Yolk sac tumors are the most common malignant among children, during
adolescence. Dysgerminoma is a very common malignant tumor (Caldamone, 2014).
The way malignant and benign gonadal cell tumors present themselves is the same; common
symptoms are the abdominal pain and lower abdominal mass.to address the nature of the
tumors the use of alpha-fetoprotein and beta subunit of the patient chorionic gonadotropin are
essentially required (Carachi, 2015).
Testicular gonadal cell tumors represent ten percent of the pediatric gonadal cell tumor of
which 30% are malignant gonadal cell tumors. The children who are less than three years are
likely to experience testicular malignant gonadal cell tumors. Adolescents are likely to show
other types of mixed tumors. For the tumors to be removed surgical process has to be carried
out in agreement with the set protocols (Carroll W. L., 2016).
Keywords: gonadal cell tumor, Yolk sac, dysgerminoma, alpha-fetoprotein, beta subunit
Introduction
The occurrence of the pediatric germ cell tumors is estimated to be 0.9 percent for children
who are up to 15 years old. There rise is mainly associated with the variations which occur
from the germ cells. Benign, immature gonadal cell germ tumors and malignant can be
observed in adolescents and children of various ages at different rates. Eighty percent of the
gonadal cell germ tumors are benign while the rest are 20%.gonadal cell tumors are known to
be the most common gonads tumors among children and young adults. However, the true
incidences of the gonadal cell tumors among children is unknown .most of these tumors in
children are curable if they are treated in their early stages. When these tumors are not
properly managed and misdiagnosed they are likely to affect the fertility of the children in the
future, malignant gonadal cell tumors in particular. Pediatricgonadal tumors have a consistent
Biological and clinical course: Many studies have published many articles concerning these
tumors. Gonadal cell tumors present themselves in many types, which includes the benign
and malignant which are further divided into other types of tumors such as the teratomas,
sinus tumor, yolk sac tumor and dysgerminoma. There are also the other types of mixed
malignant such as the primary cell tumor, embryonal carcinoma, and choriocarcinoma.
Most patients with malignant which are of high-risk tumors prefer going to the well-known
hospitals which may have dealt with such cases and led to the patient experience improving.
Surgical resection plays a very crucial role in the management and control of the gonadal cell
tumors. There are many therapies which are emerging and some already in place to manage
or control the gonadal cell tumors such therapies include:
Basic research results

5
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Chemotherapies
Mediastinal cell tumors are very sensitive to the chemotherapy. The chemotherapy has
greatly improved the survival of these tumors up to five years. Combinations of other drugs
with chemotherapy based on the dactinomycin, cyclophosphamide and vincristine has been
adopted since the 1960s due to the positive results from the combination (Coran, 2010).
Cisplatin containing the regimens were also started being used, through them the survival
rates improved in the different studies which were done and also the researches which were
carried out.
After the successful removal of the tumor, no further treatments are recommended .patients
whose tumors are not completely removed at the initial surgery they receive regular
chemotherapies (DeVita, 2012).
Immunotherapies
This is a type of gonadal cell tumors treatment which is carried out with the main aim of
boosting the body’s immunity to fight the tumor. Substances which are made in the body or
laboratory are used to restore or improve the immunity of the patient with the tumor.
Immunotherapy works in a variety of ways such as:
o Slowing down or stopping the growth of the tumor.
o Immunotherapy also ensures that the growth of the tumor does not spread to
the other parts of the body.
o Immunotherapy also works to help the immune system in destroying the
tumor.
Non-specific immunotherapies
This type of therapy helps the immune system of the body to destroy the gonadal cell tumors.
This type of therapies is administered the same time with the other treatments such as
radiotherapies.The nonspecific immunotherapies are of two types; interferon this type of the
immunotherapy helps the body to fight the tumor and it may also slow down the growth of
the tumor cells (Caldamone, 2014).
Oncolytic virus therapy
This type of the therapy uses viruses which are genetically modified to kill and destroy the
tumor cells. The Oncolytic virus therapy .the doctor injects the viruses into the tumor. Once
the viruses are in the tumor they enter the cancer cells which might have contributed to the
growth of the tumor. The cells burst and die in that way the gonadal cell tumors are destroyed
(Frazier, 2013).
T-cell therapies
T-cell is the immune cells which help to fight and destroy the tumor cells.in this type of
therapy, the t-cells is removed from the blood of the patient. The cells are then configured in
a laboratory so that they contain specific proteins which are called receptors. The receptors
have the ability to recognize the cancer cells which leads to the rise of the gonadal cell
tumors
Monoclonal antibodies therapy

6
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Once the body has detected harmful substances it produces antibodies. Antibodies refer to the
proteins which are produced by the body to fight infections.
Monoclonal antibodies are a specific type of therapy which is made in the laboratory. They
are used in a variety of ways such as applied to block a cancer cell.
Other the of the antibodies work by releases chemicals which are able to destroy the tumor
cells and flags them out of the body once they are completely destroyed (Docimo, 2011).
Radiotherapy
In a study carried out it was discovered that radiotherapy was one of the best methods in the
treatment of the gonadal cell tumors .this is because it was the most available form of
treatment. Patients who undergo radiotherapy show in their results worse OS, LRFS and PFS.
Those patients who receive radiotherapy in the first time they show more improvement after
they undergo the first radiotherapy.
According to the nature of the disease patients who have this tumor are not primarily
considered for surgery rather they are considered to be undergoing regular chemotherapy.
Most of these tumors they do not respond well to the chemotherapies (DiSaia, 2011).
In some instances, the radiotherapy is used to shrink the tumor so as to reduce its size and
reduce the burden which the tumor has to the patient. Those patients who undergo the
radiotherapy they usually show improvements in the OS and PFC, this applies particularly to
the patients who have limited diseases.
The gonadal cell tumors are extremely sensitive to the radiations but in this case, the role of
radiotherapy has not been clearly defined. The optical dosage which the patient should be
exposed to also has not been clearly defined by the therapists.
Palliative radiation therapy (Decker, 2014): palliatives radiation therapy is usually carried out
to ensure that the patient is relieved the symptoms which are associated with gonadal cell
tumors .the administration of palliative radiations improves the situation of the patients with
gonadal tumors .the exposure of the patients to this radiations also
Results from preclinical and clinical studies
Pathology: All the subtypes histological of the gonadal cell tumors may occur in the
ovary.80% of all ovarian gonadal cell tumors are comprised of immature teratomas and
benign and they are 5 % bilateral in this case. The forms of malignant are reported to be 20%
and increases when the teenagers are adolescents, and they are 10% bilateral in this case. The
York sac cell tumor is the most common malignant among young people (Daneman, 2011).
The gonadoblastoma is a gonadal cell tumor which is observed rarely in girls who have
dysgenetic gonads and in boy’s pseudo hermaphroditism.
Clinical characteristics patients with the ovarian gonadal cell tumors can be same in both in
malignant and in benign lesions; the most common symptoms which these patients have are
the 70%-80% and the lower abdominal mass.it is very hard for the tumor to be noted at its
initial stages, it can only be noticed when it has grown to the size which compresses the
neighboring parts (Carroll, 2010).

7
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Vaginal bleeding, constipation, and amenorrhea are not common symptoms.BHCG may be
produced by tumors which have trophoblastic; this may result in the breast maturing and
growth of the pubic hair (Carachi, 2015).
The nature of the tumor can be assessed by evaluation of the serum marker. Elevation of the
BHCG or FP shows the presence of a malignant. When a tumor is suspected it is better to
consider carrying out the metastatic spread. When such cases arise abdominal and thoracic
cell tumor is necessary to be carried out this is to find out the how the lungs, the
retroperitoneal LNs, and the liver were involved (Docimo, 2011).
Treatment of the malignant gonadal cell tumors.in the treatment of a patient with malignant
gonadal cell tumors, surgery plays a very important role. The surgery mainly consists the
ovariectomy or the ovariosalpingectomy. Because the malignant gonadal cell tumors are
extremely chemosensitive, one should consider primary excision. This can only happen when
the surgeon thinks that it involves a complete procedure.
The procedures of surgery can be performed by a transverse or Pfannenstiel infra-umbilical
incision this depends on the size of the lesion and the probability of a malignancy (Clarke-
Pearson, 2012).
The removal of a tumor by open surgery is very easy to carry out as it is simple and
straightforward.The surgery should follow the well laid down intraoperative and the staging
procedures. The well-defined procedures are as follows;
 Palpation and inspection of the area suspected to be having the tumor with a biopsy.
This is to enable the surgeons to be able to remove the tumor completely and ensure
that there is no further treatment which is required
 For the purpose ofcytologyperitoneal fluid is collected which will be used for washing
during the surgery.
 Consideration of removal of the ovary without damaging the tumor capsule. The
fallopian tube is greatly taken into account to ensure that there is no damage to it. If
poor procedures are administered during the surgery there is a likelihood of the tumor
capsule getting damaged. Once the tumor capsule is damaged there is a high
probability of the other organs which neighbor’s it getting damaged too thus putting
the fertility of the patient at risk (Carroll W. L., 2016).
 The omentum, liver and peritoneal is the closely examined, before the removal of any
mass within the abdominal areas this is to ensure that the areas where the mass within
the abdominal areas is where the tumor is so that to avoid doing a lot of damage to the
patient.
 Examination of the aorto-caval and iliac with the use of biopsy of any kind of
abnormal nodes
In cases where the investigation carried out shows that the organs such as the bladder,
vagina and uterus which neighbor the tumor are involved or in the case where the
malignant bilateral gonadal cell tumor is the best option preferred. The biopsy which
is to be used may be open by use of a laparoscopic method (Frazier, 2013).
From the studies carried out, they show that the biopsy is not a must requirement
because the nature of the malignant of the mass can be determined if the serum AFP
or the HCG levels are much high.
When the initial approach of surgery was a biopsy or excision by use of macroscopic
residue in the metastatic patients the chemotherapy is required.
Discussion

8
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Antibody-drug conjugates
These are very important biologics are used to see ways which they can be used to destroy
the tumor cells (Kaiser, 2013). Chemotherapy molecules are attached to a given antibody
which is targeted at a given tumor. Once the antibody gets into the body and comes across the
tumor, the chemotherapy molecule which was attached to the antibody is used to destroy the
tumor cell (Lavery, 2010).
Staging of the malignant gonadal cell tumors
Very accurate staging of the tumor during the operation process plays a very important role in
establishing the following treatment.There are two staging systems which are adopted mainly
for the pediatric ovarian malignant tumors .the children oncology group suggested a staging
system which they use, the international federation of obstetrics and gynecology staging.
Both of the staging systems are based on the outcome of the rising investigations and also the
results of the first surgical approach (Mattei, 2011).
Treatment of benign and the immature gonadal cell tumors
These are well-defined masses which have large cystic as compared to the malignant
forms .they don’t indicate elevated AFP or BHCG levels. During the first months, most of the
ovarian lesions are usually benign and they are usually detected during the antenatal
ultrasounds .many of these gonadal cell tumors can be noted some months after birth and they
stay until spontaneous regression is done.
The most effective therapy for immature gonadal cell tumors and benign is the complete
removal of the tumor (Polin, 2015), if the histological completeness has not been fully
achieved during the primary surgery. The only option is to suggest a reoperation. The
procedure for reoperation always needs the ovariectomy because of the size of mass .in cases
of small tumors the process of nucleation can be very feasible and many of the researchers
and authors advocate for this .a lot of efforts must be put in place to preserve the hormonal
balance and the reproductive functions of the patients with the bilateral benign gonadal cell
tumors (Q. Ashton Acton, 2012).
Most of the gonadal cell tumors have a very mixed structure in that malignant and immature
tumors can coexist and this makes it very hard for one to know if the lesion is malignant
before a surgery is carried out. Because of this the surgical approach should be very cautious
and in case of any doubt arise on the mass, intraoperative staging procedure method are
recommended (Raghavan, 2011).
Treatment of masses related to ovarian torsion was found to be approximately less than 10%
of all the ovarian tumors.
When a solid or mixed mass is found in the right way at the time of the abdominal
surgery .there is a need for accurate inspection of all the contents of the abdominal to
differentiate benign from the malignant masses (Schneide, 2012).
Pathology of the testis
Testicular gonadal cell tumors is about ten percent of all pediatric gonadal cell tumors
bilateral forms of tumors are exceptional .this type of gonadal cell tumors have two types of
age peak; for the children who are under the age of 3 years they may experience the two types
both the mature teratomas and malignant gonadal cell tumors (Tomlinson, 2014).

9
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
The occurrence of the testis gonadal cell tumors is highly increased in the patients who have
undescended testes. The most well-known type of these tumors is the seminoma which
usually occurs in the adolescents and young adults.
Ensures that the reproduction parts of the patient with these tumors are well safeguarded and
ensures that the productivity of the patient is not affected in any way.
Future directions
There many improvements which are expected to take place within the therapies which are
used to treat gonadal cell tumors. Such as the surgical procedures which are carried out to
ensure that the neighboring organs are not damaged and to ensure that the medical treatments
which are administered they do cause a lot of harm to the reproductive organs of the patient,
which can enable them to have biological children of their own in future.
The immunotherapies are also expected to greatly improve because of the various practices of
biological innovations which are in laborites in different parts of the world. Immunotherapy
was considered to be the most convenient and safe way of treating gonadal cell tumors
because it doesn’t involve any form of surgery. Major improvements are also expected to be
done to the radiotherapy because as it is by now there its application is not well established,
in term of the amount of radiations which a patient should be exposed to and the area of
application. Once those improvements have been done the results of patients who undergo
radiotherapy will improve.
Conclusion
In conclusion, the pediatric gonadal germ cell tumors are greatly increasing among young
children and young adults in the recent years. The cause behind the high number of cases is
not yet clear and due to the many types of tumors which are rising, the role of surgical
resection which has not yet been clearly defined in the treatment of the gonadal cell tumors.
Many pharmacists and doctors have put in place a lot of efforts to ensure that there are many
therapies for the gonadal cell tumors which are used in the treatment. There is a wide range of
therapies such as the chemotherapies, radiotherapies, immunotherapies, non-specific
therapies and among many others. Since the introduction of the therapies, there has a positive
improvement of the patients who undergo the treatments.
References
Acton, A. (2012). Issues in Cancer Drugs and Therapies: 2011 Edition. Berlin:
ScholarlyEditions.

10
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Amatruda, J. F. (2015). Pediatric Germ Cell Tumors: Biology Treatment Survivorship.
London: Springer Science & Business Media.
Baraka, R. R. (2010). Principles and Practice of Gynecologic Oncology. New York:
Lippincott Williams & Wilkins.
Bleyer, A. W. (2016). Cancer in Adolescents and Young Adults. London: Springer Science &
Business Media.
Brook, C. G. (2012). Handbook of Clinical Pediatric Endocrinology. Chicago: John Wiley &
Sons.
Caldamone, A. (2014). Pediatric Surgery E-Book. Chicago: Elsevier Health Sciences.
Carachi, R. (2015). The Surgery of Childhood Tumors. Texas: Springer Science & Business
Media.
Carroll. (2010). Cancer in Children and Adolescents. Paris: Jones & Bartlett Publishers.
Carroll, W. L. (2016). Cancer in Children and Adolescents. Sidney: Jones & Bartlett
Publishers.
Clarke-Pearson. (2012). Gynecological Cancer Management: Identification, Diagnosis and
Treatment. Los Angels: John Wiley & Sons.
Coran, A. G. (2010). Pediatric Surgery. Berlin: Elsevier Health Sciences.
Daneman, A. (2011). Pediatric Body CT. London: Springer Science & Business Media.
Decker. (2014). Current Therapy in Pediatrics, Volume 2. Sidney: Heinz F. Eichenwald.
DeVita, V. T. (2012). DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of
Oncology, Volume 2. Sidney: Lippincott Williams & Wilkins.
DiSaia, P. J. (2011). Clinical Gynecologic Oncology E-Book. London: Elsevier Health
Sciences.
Docimo, S. G. (2011). Minimally Invasive Approaches to Pediatric Urology. London: CRC
Press.
Frazier, A. L. (2013). Pediatric Germ Cell Tumors: Biology Treatment Survivorship.
Newyork: Springer Science & Business Media.
Kaiser, G. L. (2013). Symptoms and Signs in Pediatric Surgery. Chicago: Springer Science &
Business Media.
Lavery, J. (2010). Pediatric and Adolescent Obstetrics and Gynecology. Sidney: Springer
Science & Business Media.
Mattei, P. (2011). Fundamentals of Pediatric Surgery. Texas: Springer Science & Business
Media.
Polin, R. A. (2015). Pediatric Secrets E-Book. New York: Elsevier Health Sciences.

11
CURRENT & EMERGING THERAPIES FOR PEDIATRIC GONADAL GERM CELL
Q. Ashton Acton. (2012). Issues in Cancer Drugs and Therapies: 2011 Edition. Berlin:
ScholarlyEditions.
Raghavan, D. (2011). Germ Cell Tumors. Cichago: PMPH-USA.
Schneide, D. (2012). Rare Tumors In Children and Adolescents. Paris: Springer Science &
Business Media.
Tomlinson, D. (2014). Pediatric Oncology Nursing: Advanced Clinical Handbook. London:
Springer Science & Business Media.